Selected research
Market Structure
Global Sterile Water for Injection (SWFI) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Sterile Water for Injection (SWFI) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Sterile Water for Injection (SWFI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Sterile Water for Injection (SWFI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Sterile Water for Injection (SWFI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Sterile Water for Injection (SWFI) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Sterile Water for Injection (SWFI) include Zhuhai Tongyuan Pharmaceutical, Zhejiang Tianrui Pharmaceutical, Shapuaisi Pharma, Shandong Qidu Pharma Group, Pfizer(Hospira), Fresenius Kabi, B. Braun Medical Inc., Baxter Corporation and SSY Group Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Sterile Water for Injection (SWFI) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Sterile Water for Injection (SWFI) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Sterile Water for Injection (SWFI) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sterile Water for Injection (SWFI) market size, projected growth trends, production technologies, key applications, and end-use industries.
Sterile Water for Injection (SWFI) Segment by Company
Zhuhai Tongyuan Pharmaceutical
Zhejiang Tianrui Pharmaceutical
Shapuaisi Pharma
Shandong Qidu Pharma Group
Pfizer(Hospira)
Fresenius Kabi
B. Braun Medical Inc.
Baxter Corporation
SSY Group Limited
Kelun
Huaren
Hikma
Deo Gratias Parenteral
China Otsuka
Sterile Water for Injection (SWFI) Segment by Type
Vials
Glass Bottles
Pre-filled Syringes
Sterile Water for Injection (SWFI) Segment by Application
Hospital
Clinics
Others
Sterile Water for Injection (SWFI) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sterile Water for Injection (SWFI) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sterile Water for Injection (SWFI) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sterile Water for Injection (SWFI).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Sterile Water for Injection (SWFI) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sterile Water for Injection (SWFI) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sterile Water for Injection (SWFI) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Sterile Water for Injection (SWFI) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Vials
- Glass Bottles
- Pre-filled Syringes
Applications
- Hospital
- Clinics
- Others
Companies covered
- Zhuhai Tongyuan Pharmaceutical
- Zhejiang Tianrui Pharmaceutical
- Shapuaisi Pharma
- Shandong Qidu Pharma Group
- Pfizer(Hospira)
- Fresenius Kabi
- B. Braun Medical Inc.
- Baxter Corporation
- SSY Group Limited
- Kelun
- Huaren
- Hikma
- Deo Gratias Parenteral
- China Otsuka
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Sterile Water for Injection (SWFI) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Sterile Water for Injection (SWFI) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Sterile Water for Injection (SWFI) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Sterile Water for Injection (SWFI) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Sterile Water for Injection (SWFI) Market Dynamics
- 2.1 Sterile Water for Injection (SWFI) Industry Trends
- 2.2 Sterile Water for Injection (SWFI) Industry Drivers
- 2.3 Sterile Water for Injection (SWFI) Industry Opportunities and Challenges
- 2.4 Sterile Water for Injection (SWFI) Industry Restraints
3 Sterile Water for Injection (SWFI) Market by Manufacturers
- 3.1 Global Sterile Water for Injection (SWFI) Revenue by Manufacturers (2021-2026)
- 3.2 Global Sterile Water for Injection (SWFI) Sales by Manufacturers (2021-2026)
- 3.3 Global Sterile Water for Injection (SWFI) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Sterile Water for Injection (SWFI) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Sterile Water for Injection (SWFI) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Sterile Water for Injection (SWFI) Manufacturers, Product Type & Application
- 3.7 Global Sterile Water for Injection (SWFI) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Sterile Water for Injection (SWFI) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Sterile Water for Injection (SWFI) Players Market Share by Revenue in 2025
- 3.8.3 2025 Sterile Water for Injection (SWFI) Tier 1, Tier 2, and Tier 3
4 Sterile Water for Injection (SWFI) Market by Type
- 4.1 Sterile Water for Injection (SWFI) Type Introduction
- 4.1.1 Vials
- 4.1.2 Glass Bottles
- 4.1.3 Pre-filled Syringes
- 4.2 Global Sterile Water for Injection (SWFI) Sales by Type
- 4.2.1 Global Sterile Water for Injection (SWFI) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Sterile Water for Injection (SWFI) Sales by Type (2021-2032)
- 4.2.3 Global Sterile Water for Injection (SWFI) Sales Market Share by Type (2021-2032)
- 4.3 Global Sterile Water for Injection (SWFI) Revenue by Type
- 4.3.1 Global Sterile Water for Injection (SWFI) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Sterile Water for Injection (SWFI) Revenue by Type (2021-2032)
- 4.3.3 Global Sterile Water for Injection (SWFI) Revenue Market Share by Type (2021-2032)
5 Sterile Water for Injection (SWFI) Market by Application
- 5.1 Sterile Water for Injection (SWFI) Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Sterile Water for Injection (SWFI) Sales by Application
- 5.2.1 Global Sterile Water for Injection (SWFI) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Sterile Water for Injection (SWFI) Sales by Application (2021-2032)
- 5.2.3 Global Sterile Water for Injection (SWFI) Sales Market Share by Application (2021-2032)
- 5.3 Global Sterile Water for Injection (SWFI) Revenue by Application
- 5.3.1 Global Sterile Water for Injection (SWFI) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Sterile Water for Injection (SWFI) Revenue by Application (2021-2032)
- 5.3.3 Global Sterile Water for Injection (SWFI) Revenue Market Share by Application (2021-2032)
6 Global Sterile Water for Injection (SWFI) Sales by Region
- 6.1 Global Sterile Water for Injection (SWFI) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Sterile Water for Injection (SWFI) Sales by Region (2021-2032)
- 6.2.1 Global Sterile Water for Injection (SWFI) Sales by Region (2021-2026)
- 6.2.2 Global Sterile Water for Injection (SWFI) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Sterile Water for Injection (SWFI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Sterile Water for Injection (SWFI) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Sterile Water for Injection (SWFI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Sterile Water for Injection (SWFI) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Sterile Water for Injection (SWFI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Sterile Water for Injection (SWFI) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Sterile Water for Injection (SWFI) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Sterile Water for Injection (SWFI) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Sterile Water for Injection (SWFI) Revenue by Region
- 7.1 Global Sterile Water for Injection (SWFI) Revenue by Region
- 7.1.1 Global Sterile Water for Injection (SWFI) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Sterile Water for Injection (SWFI) Revenue by Region (2021-2026)
- 7.1.3 Global Sterile Water for Injection (SWFI) Revenue by Region (2027-2032)
- 7.1.4 Global Sterile Water for Injection (SWFI) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Sterile Water for Injection (SWFI) Revenue (2021-2032)
- 7.2.2 North America Sterile Water for Injection (SWFI) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Sterile Water for Injection (SWFI) Revenue (2021-2032)
- 7.3.2 Europe Sterile Water for Injection (SWFI) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Sterile Water for Injection (SWFI) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Sterile Water for Injection (SWFI) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Sterile Water for Injection (SWFI) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Sterile Water for Injection (SWFI) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Zhuhai Tongyuan Pharmaceutical
- 8.1.1 Zhuhai Tongyuan Pharmaceutical Company Information
- 8.1.2 Zhuhai Tongyuan Pharmaceutical Business Overview
- 8.1.3 Zhuhai Tongyuan Pharmaceutical Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Zhuhai Tongyuan Pharmaceutical Sterile Water for Injection (SWFI) Product Portfolio
- 8.1.5 Zhuhai Tongyuan Pharmaceutical Recent Developments
- 8.2 Zhejiang Tianrui Pharmaceutical
- 8.2.1 Zhejiang Tianrui Pharmaceutical Company Information
- 8.2.2 Zhejiang Tianrui Pharmaceutical Business Overview
- 8.2.3 Zhejiang Tianrui Pharmaceutical Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Zhejiang Tianrui Pharmaceutical Sterile Water for Injection (SWFI) Product Portfolio
- 8.2.5 Zhejiang Tianrui Pharmaceutical Recent Developments
- 8.3 Shapuaisi Pharma
- 8.3.1 Shapuaisi Pharma Company Information
- 8.3.2 Shapuaisi Pharma Business Overview
- 8.3.3 Shapuaisi Pharma Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Shapuaisi Pharma Sterile Water for Injection (SWFI) Product Portfolio
- 8.3.5 Shapuaisi Pharma Recent Developments
- 8.4 Shandong Qidu Pharma Group
- 8.4.1 Shandong Qidu Pharma Group Company Information
- 8.4.2 Shandong Qidu Pharma Group Business Overview
- 8.4.3 Shandong Qidu Pharma Group Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Shandong Qidu Pharma Group Sterile Water for Injection (SWFI) Product Portfolio
- 8.4.5 Shandong Qidu Pharma Group Recent Developments
- 8.5 Pfizer(Hospira)
- 8.5.1 Pfizer(Hospira) Company Information
- 8.5.2 Pfizer(Hospira) Business Overview
- 8.5.3 Pfizer(Hospira) Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer(Hospira) Sterile Water for Injection (SWFI) Product Portfolio
- 8.5.5 Pfizer(Hospira) Recent Developments
- 8.6 Fresenius Kabi
- 8.6.1 Fresenius Kabi Company Information
- 8.6.2 Fresenius Kabi Business Overview
- 8.6.3 Fresenius Kabi Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Fresenius Kabi Sterile Water for Injection (SWFI) Product Portfolio
- 8.6.5 Fresenius Kabi Recent Developments
- 8.7 B. Braun Medical Inc.
- 8.7.1 B. Braun Medical Inc. Company Information
- 8.7.2 B. Braun Medical Inc. Business Overview
- 8.7.3 B. Braun Medical Inc. Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 B. Braun Medical Inc. Sterile Water for Injection (SWFI) Product Portfolio
- 8.7.5 B. Braun Medical Inc. Recent Developments
- 8.8 Baxter Corporation
- 8.8.1 Baxter Corporation Company Information
- 8.8.2 Baxter Corporation Business Overview
- 8.8.3 Baxter Corporation Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Baxter Corporation Sterile Water for Injection (SWFI) Product Portfolio
- 8.8.5 Baxter Corporation Recent Developments
- 8.9 SSY Group Limited
- 8.9.1 SSY Group Limited Company Information
- 8.9.2 SSY Group Limited Business Overview
- 8.9.3 SSY Group Limited Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 SSY Group Limited Sterile Water for Injection (SWFI) Product Portfolio
- 8.9.5 SSY Group Limited Recent Developments
- 8.10 Kelun
- 8.10.1 Kelun Company Information
- 8.10.2 Kelun Business Overview
- 8.10.3 Kelun Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Kelun Sterile Water for Injection (SWFI) Product Portfolio
- 8.10.5 Kelun Recent Developments
- 8.11 Huaren
- 8.11.1 Huaren Company Information
- 8.11.2 Huaren Business Overview
- 8.11.3 Huaren Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Huaren Sterile Water for Injection (SWFI) Product Portfolio
- 8.11.5 Huaren Recent Developments
- 8.12 Hikma
- 8.12.1 Hikma Company Information
- 8.12.2 Hikma Business Overview
- 8.12.3 Hikma Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Hikma Sterile Water for Injection (SWFI) Product Portfolio
- 8.12.5 Hikma Recent Developments
- 8.13 Deo Gratias Parenteral
- 8.13.1 Deo Gratias Parenteral Company Information
- 8.13.2 Deo Gratias Parenteral Business Overview
- 8.13.3 Deo Gratias Parenteral Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Deo Gratias Parenteral Sterile Water for Injection (SWFI) Product Portfolio
- 8.13.5 Deo Gratias Parenteral Recent Developments
- 8.14 China Otsuka
- 8.14.1 China Otsuka Company Information
- 8.14.2 China Otsuka Business Overview
- 8.14.3 China Otsuka Sterile Water for Injection (SWFI) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 China Otsuka Sterile Water for Injection (SWFI) Product Portfolio
- 8.14.5 China Otsuka Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Sterile Water for Injection (SWFI) Value Chain Analysis
- 9.1.1 Sterile Water for Injection (SWFI) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Sterile Water for Injection (SWFI) Production Mode & Process
- 9.2 Sterile Water for Injection (SWFI) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Sterile Water for Injection (SWFI) Distributors
- 9.2.3 Sterile Water for Injection (SWFI) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst